The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people...
Vous n'êtes pas connecté
Findings on early viral and immune markers provide insights into the pathogenesis of post-acute sequelae of SARS-CoV-2, informing future research and therapies.
The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people...
The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people...
A team at Nagoya University Graduate School of Medicine has found that the enzyme protein kinase N (PKN) plays a role in cardiac fibrosis linked to...
A team at Nagoya University Graduate School of Medicine has found that the enzyme protein kinase N (PKN) plays a role in cardiac fibrosis linked to...
Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the virus that causes COVID-19, as well as distantly...
The Wuhan Institute of Virology has developed a new nasal Covid-19 vaccine intended to offer extensive protection against existing and future...
Starting antiviral treatment as late as 14 days after infection with SARS-CoV-2 may still be beneficial in hosts with compromised immune systems, who...
A new study shows that women can have menopause symptoms, like hot flashes, for longer than expected. Because of this, more research is looking at...
Aerosolized mucosal vaccines show promise in controlling SARS-CoV-2, offering greater protection and immune response than intramuscular bivalent mRNA...
Aerosolized mucosal vaccines show promise in controlling SARS-CoV-2, offering greater protection and immune response than intramuscular bivalent mRNA...